After a post-doc in Oxford, François joined EUROPEPTIDES (BU of Mediolanum then ASTA MEDICA) where he held the position of VP R&D. During this years, Francois developed several peptide based products among which injectable depots of GnRH agonists and antagonists (biodegradable implants, microspheres, microcrystals). Francois co-founded APTYS Pharmaceuticals in 2002 after the acquisition of patents rights on delivery technology from the University of Auvergne.
Michel holds a Doctorate in Pharmacy and a PhD in Pharmaco-Chemistry. He has 26 years of international pharmaceutical industry experience including Auditing, Quality Assurance, Process Validation, Project Management and Business Development. His main position was Regional Bussiness Operation Director for Europe, Eastern Europe and Middle-East/Africa region.
Michel has also been Responsible Pharmacist of MERCK SHARP & DOHME France and member of the Executive Committee. He managed the whole french subsidary regulatory activities : clinical studies, registration, medical information control, sales forces training, compliance of the “exploitant” activities, quality assurance system of the headquarters and of the 2 sterile production plants.